Radiotherapy Effect on Long-Term Net Survival Benefit for Early-Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era

被引：0
|
作者：
Wang, X. [1 ]
Qi, S. [1 ]
Liu, X. [1 ]
Wu, Y. [1 ]
Wang, J. [1 ]
Luo, F. [1 ]
Liu, Y. [1 ]
Li, Y. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc,Canc Hosp, Natl Canc Ctr, Dept Radiat Oncol, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3073
引用
收藏
页码：E492 / E492
页数：1
相关论文
共 50 条
  • [1] Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era
    Wang, Xin
    Liu, Xin
    Zhong, Qiu-Zi
    Wu, Tao
    Wu, Yun-Peng
    Yang, Yong
    Chen, Bo
    Jing, Hao
    Tang, Yuan
    Jin, Jing
    Liu, Yue-Ping
    Song, Yong -Wen
    Fang, Hui
    Lu, Ning-Ning
    Li, Ning
    Zhai, Yi-Rui
    Zhang, Wen -Wen
    Wang, Shu-Lian
    Chen, Fan
    Qi, Shu-Nan
    Li, Ye-Xiong
    RADIOTHERAPY AND ONCOLOGY, 2023, 188
  • [2] Patient Survival with and Without Radiotherapy for Early Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab
    McLaughlin, C.
    Slade, A. N.
    Mukhopadhyay, N. D.
    Song, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S248 - S248
  • [3] Benefit of Consolidative Radiotherapy in Patients with Limited Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Nakamura, Nobuhiko
    Ikoma, Yoshikazu
    Shibata, Yuhei
    Matsumoto, Takuro
    Ninomiya, Soranobu
    Kitagawa, Junichi
    Shimizu, Masahito
    Hara, Takeshi
    Tsurumi, Hisashi
    BLOOD, 2016, 128 (22)
  • [4] Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab
    McLaughlin, Christopher
    Ricco, Anthony
    Singh, Raj
    Mukhopadhyay, Nitai
    Skoro, Nevena
    Girma, Selamawit
    Deng, Xiaoyan
    Song, Shiyu
    ADVANCES IN RADIATION ONCOLOGY, 2021, 7 (04)
  • [5] Rituximab for early-stage diffuse large-B-cell lymphoma
    Friedberg, Jonathan W.
    LANCET ONCOLOGY, 2006, 7 (05): : 357 - 359
  • [6] Long-Term Outcomes For Stage I-II Diffuse Large B-Cell Lymphoma Treated With Rituximab And Chemotherapy With Or Without Radiotherapy
    Binkley, M. S.
    Hiniker, S. M.
    Younes, S.
    Yoo, C.
    Wignarajah, K.
    Jin, M.
    Guo, H. H.
    Natkunam, Y.
    Advani, R. H.
    Hoppe, R. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E758 - E758
  • [7] Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era
    Flowers, Christopher R.
    Cohen, Jonathon B.
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 557 - 558
  • [8] Updates in the Management of Early-Stage Diffuse Large B-Cell Lymphoma
    Habermann, Thomas M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1324 - 1326
  • [9] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [10] Reduced radiotherapy clinical benefit for primary Waldeyer's ring diffuse large B-cell lymphoma in the rituximab era
    Guan, Qingpei
    Hong, Yuheng
    Hu, Ge
    Zhou, Qiqi
    Li, Lanfang
    Qian, Zhengzi
    Zhou, Shiyong
    Ren, Xiubao
    Qiu, Lihua
    Wang, Xianhuo
    Zhang, Huilai
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (04) : 490 - 497
12345